Nasdaq · CIK 0000899923
MYGN MYRIAD GENETICS INC
Insider trading from SEC Form 4. Last filing 20 d ago. Close $4.31 on Oct 9, 2026, +51% from the 52-week low and -47% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
18
with a Form 4 at this company
Price and insider trades, last year
MYGNOct 9, 2026 · close 4.31
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MYRIAD GENETICS INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Paul J Diaz President and CEO sell | $344k 15,000 shares | -2% | - |
Transactions
The last 49 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Benjamin Richard Wheeler Chief Financial Officer | FTax withholding Common Stock | -2,555 | $4.01 | $10k | 287,193 | 20 d ago |
| Sep 16, 2026 | Vishal Sikri EVP, Commercial | AGrant or award Common Stock | +257,731 | $0.00 | $0 | 351,224 | 25 d ago |
| Sep 3, 2026 | Jennifer Lynne Fox Chief Legal Officer | FTax withholding Common Stock | -4,398 | $3.23 | $14k | 305,964 | 34 d ago |
| Sep 21, 2025 | Margaret Ancona EVP, Strategy & Transformation | FTax withholding Common Stock | -958 | $7.77 | $7,444 | 127,726 | Sep 22, 2025 |
| Sep 3, 2025 | Jennifer Lynne Fox Chief Legal Officer | FTax withholding Common Stock | -4,435 | $6.80 | $30k | 120,481 | Sep 4, 2025 |
| Jun 5, 2025 | Paul Bisaro director | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 89,941 | Jun 6, 2025 |
| Jun 5, 2025 | Mark Steven Davis director | AGrant or award Common Stock | +24,148 | $0.00 | $0 | 46,964 | Jun 6, 2025 |
| Jun 5, 2025 | Heinrich Dreismann director | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 171,444 | Jun 6, 2025 |
| Jun 5, 2025 | Rashmi Kumar director | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 127,188 | Jun 6, 2025 |
| Jun 5, 2025 | Daniel Skovronsky director | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 135,806 | Jun 6, 2025 |
| Jun 5, 2025 | Colleen F Reitan director | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 92,329 | Jun 6, 2025 |
| Jun 5, 2025 | Lee Nisley Newcomer director | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 132,141 | Jun 6, 2025 |
| Jun 5, 2025 | S. Louise Phanstiel director | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 177,444 | Jun 6, 2025 |
| May 31, 2025 | Samraat S. Raha President and CEO | AGrant or award Common Stock | +1,498 | $3.56 | $5,336 | 482,738 | Jun 2, 2025 |
| May 1, 2025 | Brian J Donnelly Chief Commerical Officer | AGrant or award Common Stock | +269,905 | $0.00 | $0 | 269,905 | May 2, 2025 |
| May 1, 2025 | Brian J Donnelly Chief Commerical Officer | AGrant or award Common Stock | +127,629 | $0.00 | $0 | 397,534 | May 2, 2025 |
| May 1, 2025 | Brian J Donnelly Chief Commerical Officer | AGrant or award Performance-Based Restricted Stock Unitsderivative | +236,167 | $0.00 | $0 | 236,167 | May 2, 2025 |
| Apr 30, 2025 | Mark Verratti Chief Operating Officer | AGrant or award Performance-Based Restricted Stock Unitsderivative | +105,785 | $0.00 | $0 | 105,785 | May 1, 2025 |
| Apr 30, 2025 | Samraat S. Raha President and CEO | AGrant or award Performance-Based Restricted Stock Unitsderivative | +141,050 | $0.00 | $0 | 141,050 | May 1, 2025 |
| Apr 14, 2025 | Mark Verratti Chief Commercial Officer | FTax withholding Common Stock | -1,085 | $8.08 | $8,767 | 382,911 | Apr 15, 2025 |
| Apr 14, 2025 | Dale Muzzey Chief Scientific Officer | FTax withholding Common Stock | -942 | $8.08 | $7,611 | 170,599 | Apr 15, 2025 |
| Mar 22, 2025 | Margaret Ancona SVP, Chief of Staff | FTax withholding Common Stock | -718 | $10.01 | $7,187 | 130,588 | Mar 25, 2025 |
| Mar 22, 2025 | Paul J Diaz President and CEO | FTax withholding Common Stock | -19,859 | $10.01 | $199k | 989,665 | Mar 25, 2025 |
| Mar 22, 2025 | Kevin Richard Haas Chief Technology Officer | FTax withholding Common Stock | -1,694 | $10.01 | $17k | 186,029 | Mar 25, 2025 |
| Mar 22, 2025 | Kevin Richard Haas Chief Technology Officer | FTax withholding Common Stock | -4,493 | $10.01 | $45k | 181,536 | Mar 25, 2025 |
| Mar 22, 2025 | Margaret Ancona SVP, Chief of Staff | FTax withholding Common Stock | -1,904 | $10.01 | $19k | 128,684 | Mar 25, 2025 |
| Mar 22, 2025 | Paul J Diaz President and CEO | FTax withholding Common Stock | -52,682 | $10.01 | $527k | 936,983 | Mar 25, 2025 |
| Mar 24, 2025 | Paul J Diaz President and CEO | FTax withholding Common Stock | -18,312 | $9.98 | $183k | 918,671 | Mar 25, 2025 |
| Mar 24, 2025 | Kevin Richard Haas Chief Technology Officer | FTax withholding Common Stock | -1,177 | $9.98 | $12k | 180,359 | Mar 25, 2025 |
| Mar 24, 2025 | Kevin Richard Haas Chief Technology Officer | FTax withholding Common Stock | -1,724 | $9.98 | $17k | 178,635 | Mar 25, 2025 |
| Mar 24, 2025 | Paul J Diaz President and CEO | FTax withholding Common Stock | -26,827 | $9.98 | $268k | 891,844 | Mar 25, 2025 |
| Mar 13, 2025 | Kevin Richard Haas Chief Technology Officer | AGrant or award Common Stock | +54,124 | $0.00 | $0 | 195,448 | Mar 17, 2025 |
| Mar 14, 2025 | Paul J Diaz President and CEO | FTax withholding Common Stock | -37,564 | $10.07 | $378k | 1,039,642 | Mar 17, 2025 |
| Mar 13, 2025 | Margaret Ancona SVP, Chief of Staff | AGrant or award Common Stock | +54,124 | $0.00 | $0 | 136,295 | Mar 17, 2025 |
| Mar 13, 2025 | Jennifer Lynne Fox Chief Legal Officer | AGrant or award Common Stock | +63,145 | $0.00 | $0 | 124,916 | Mar 17, 2025 |
| Mar 15, 2025 | Paul J Diaz President and CEO | FTax withholding Common Stock | -30,118 | $10.07 | $303k | 1,009,524 | Mar 17, 2025 |
| Mar 14, 2025 | Margaret Ancona SVP, Chief of Staff | FTax withholding Common Stock | -3,417 | $10.07 | $34k | 132,878 | Mar 17, 2025 |
| Mar 14, 2025 | Kevin Richard Haas Chief Technology Officer | FTax withholding Common Stock | -4,390 | $10.07 | $44k | 191,058 | Mar 17, 2025 |
| Mar 15, 2025 | Margaret Ancona SVP, Chief of Staff | FTax withholding Common Stock | -1,572 | $10.07 | $16k | 131,306 | Mar 17, 2025 |
| Mar 15, 2025 | Kevin Richard Haas Chief Technology Officer | FTax withholding Common Stock | -3,335 | $10.07 | $34k | 187,723 | Mar 17, 2025 |
| Feb 7, 2025 | Margaret Ancona SVP, Chief of Staff | AGrant or award Common Stock | +6,468 | $0.00 | $0 | 82,171 | Mar 4, 2025 |
| Feb 7, 2025 | Paul J Diaz President and CEO | AGrant or award Common Stock | +114,828 | $0.00 | $0 | 1,077,206 | Mar 4, 2025 |
| Feb 7, 2025 | Kevin Richard Haas Chief Technology Officer | AGrant or award Common Stock | +12,758 | $0.00 | $0 | 141,324 | Mar 4, 2025 |
| Feb 25, 2025 | Margaret Ancona SVP, Chief of Staff | FTax withholding Common Stock | -2,697 | $11.74 | $32k | 75,703 | Feb 26, 2025 |
| Feb 25, 2025 | Kevin Richard Haas Chief Technology Officer | FTax withholding Common Stock | -1,016 | $11.74 | $12k | 128,566 | Feb 26, 2025 |
| Dec 11, 2024 | Samraat S. Raha Chief Operating Officer | FTax withholding Common Stock | -29,578 | $14.51 | $429k | 272,394 | Dec 12, 2024 |
| Dec 10, 2024 | Mark Steven Davis director | AGrant or award Common Stock | +22,816 | $0.00 | $0 | 22,816 | Dec 11, 2024 |
| Nov 30, 2024 | Samraat S. Raha Chief Operating Officer | AGrant or award Common Stock | +1,118 | $13.83 | $15k | 301,972 | Dec 2, 2024 |
| Oct 11, 2024 | Paul J Diaz President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $22.93 | $344k | 962,378 | Oct 11, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Margaret AnconaEVP, Strategy & Transformation
- Paul Bisarodirector
- Paul J DiazPresident and CEO
- Mark Steven Davisdirector
- Brian J DonnellyChief Commerical Officer
- Heinrich Dreismanndirector
- Jennifer Lynne FoxChief Legal Officer
- Kevin Richard HaasChief Technology Officer
- Rashmi Kumardirector
- Dale MuzzeyChief Scientific Officer
- Lee Nisley Newcomerdirector
- S. Louise Phanstieldirector
- Samraat S. RahaPresident and CEO
- Colleen F Reitandirector
- Vishal SikriEVP, Commercial
- Daniel Skovronskyofficer, director
- Mark VerrattiChief Operating Officer
- Benjamin Richard WheelerChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.